Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr747 Inhibitors

Olr747 inhibitors are a specialized class of chemical compounds that function by specifically targeting and inhibiting the activity of the Olr747 receptor. This receptor is part of a larger family of G-protein coupled receptors (GPCRs) that are critical in various cellular signaling pathways. The inhibition of Olr747 typically involves binding to the active site of the receptor, thereby preventing the normal ligand from initiating its signal transduction cascade. The structural complexity of these inhibitors often includes a core scaffold that interacts with key amino acids in the receptor's binding pocket, stabilizing the inactive conformation of Olr747. This stabilization is crucial for effectively halting the downstream signaling processes that would normally be triggered by the receptor's activation.

The design and synthesis of Olr747 inhibitors require an in-depth understanding of the receptor's structure, often derived from advanced techniques such as X-ray crystallography or cryo-electron microscopy. Researchers utilize this structural information to identify potential binding sites and to guide the rational design of molecules with high affinity and specificity for Olr747. Additionally, computational methods such as molecular docking and dynamics simulations are employed to predict the binding interactions and optimize the inhibitor molecules. The development of Olr747 inhibitors also involves extensive chemical modifications and optimizations to enhance their stability, solubility, and overall efficacy as receptor antagonists. By meticulously fine-tuning these properties, researchers can create inhibitors that are not only potent but also possess desirable pharmacokinetic characteristics for further research and study.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Beta-adrenergic antagonist, might modulate GPCR activity affecting Olr747.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

Beta-adrenergic antagonist with alpha-1 blocking activity, could influence Olr747 signaling.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$51.00
$171.00
$530.00
2
(1)

Alpha-2 adrenergic receptor antagonist, may affect GPCR signaling pathways related to Olr747.

Labetalol

36894-69-6sc-484723
50 mg
$180.00
(0)

Combined alpha and beta blocker, could indirectly affect GPCR pathways including Olr747.

Pindolol

13523-86-9sc-204847
sc-204847A
100 mg
1 g
$194.00
$760.00
(1)

Beta-adrenergic antagonist, may influence GPCR-mediated signaling pathways related to Olr747.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Beta-adrenergic agonist, could indirectly affect Olr747 through GPCR modulation.

Atropine

51-55-8sc-252392
5 g
$204.00
2
(1)

Muscarinic acetylcholine receptor antagonist, may influence GPCR signaling pathways including Olr747.

Salmeterol

89365-50-4sc-224277
sc-224277A
10 mg
50 mg
$186.00
$562.00
1
(1)

Beta-2 adrenergic agonist, potentially affecting GPCR pathways related to Olr747.

Alprenolol

13655-52-2sc-507469
50 mg
$130.00
(0)

Beta blocker, could indirectly influence GPCR signaling pathways including Olr747.